Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × Surgical Procedures, Operative × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 4 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Glioblastoma 3 Breast Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasms 2 Melanoma 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1

Interventions

Standard of Care 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Quercetin 1 Methods 1 Flavonoids 1 Enhanced Recovery After Surgery 1 Dasatinib 1 Chemotherapy, Adjuvant 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06089083 2026-01-26

PROOF

University of California, San Francisco

Frailty, Genital Neoplasms, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡